Celldex Therapeutics, Inc. Current Assets
Celldex Therapeutics, Inc. (CLDX) had Current Assets of $724.93 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-06
- 2026-06-30: Assets, Current $724.93M.
- 2026-03-31: Assets, Current $459.22M.
- 2025-12-31: Assets, Current $534.66M.
- 2025-09-30: Assets, Current $604.34M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $724.93M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $459.22M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $534.66M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $604.34M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $648.40M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $693.76M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $747.16M 10-K · filed 2026-02-25 |
| 2024-09-30 | $778.84M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $811.98M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $835.32M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $431.69M 10-K · filed 2025-02-27 |
| 2023-09-30 | $245.93M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $264.82M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $289.60M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $317.69M 10-K · filed 2024-02-26 |
| 2022-09-30 | $334.60M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $367.98M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $390.70M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $410.84M 10-K · filed 2023-02-28 |
| 2021-09-30 | $426.56M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $167.61M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $181.50M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $197.84M 10-K · filed 2022-02-28 |
| 2020-09-30 | $202.93M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $208.99M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $55.92M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $66.70M 10-K · filed 2021-03-29 |
| 2019-09-30 | $75.10M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $84.36M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $88.85M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $99.08M 10-K · filed 2020-03-26 |
| 2018-09-30 | $110.97M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $120.28M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $130.97M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $144.76M 10-K · filed 2019-03-07 |
| 2017-09-30 | $147.32M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $160.05M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $173.46M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $195.57M 10-K · filed 2018-03-07 |
| 2016-09-30 | $209.71M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $228.78M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $260.95M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $294.94M 10-K · filed 2017-03-14 |
| 2015-09-30 | $309.26M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $339.54M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $364.13M 10-Q · filed 2015-04-29 |
| 2014-12-31 | $204.99M 10-K/A · filed 2016-02-25 |
| 2014-09-30 | $229.82M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $255.60M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $276.82M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $305.19M 10-K · filed 2015-02-24 |
| 2013-09-30 | $139.95M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $156.43M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $184.45M 10-Q · filed 2013-05-03 |
| 2012-12-31 | $85.11M 10-K · filed 2014-03-03 |
| 2012-09-30 | $78.81M 10-Q · filed 2012-11-02 |
| 2012-06-30 | $80.40M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $94.24M 10-Q · filed 2012-05-04 |
| 2011-12-31 | $54.68M 10-K · filed 2013-03-08 |
| 2011-09-30 | $64.38M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $73.29M 10-Q · filed 2011-08-04 |
| 2010-12-31 | $62.95M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |